We discuss how new approaches are illuminating the factors that determine the responses to PRL, including intrinsic tumor cell properties and the microenvironment, and point to directions for future studies that will integrate our understanding of this hormone in breast cancer progression and therapeutic responses. The gene discussed is PRL; the disease is breast cancer.